Mann W, Maurer J
Universitäts-Hals-Nasen-Ohrenklinik Mainz.
Laryngorhinootologie. 1990 Mar;69(3):158-60. doi: 10.1055/s-2007-998165.
A prospective perioperative trial with cefotiam and metronidazol was carried out in 114 patients undergoing head and neck surgery. The patients were stratified in one group receiving a single-dose prophylaxis and a second group receiving a 24-hour prophylaxis. The postoperative complication rates were analysed depending on various risk factors and the size and duration of surgery. For operations of similar size the long term prophylaxis had no advantage over the one-dose prophylaxis. It is concluded that a one-dose prophylaxis appears sufficient in major head and neck cases.
对114例接受头颈外科手术的患者进行了一项关于头孢替安和甲硝唑的前瞻性围手术期试验。患者被分为两组,一组接受单剂量预防用药,另一组接受24小时预防用药。根据各种风险因素以及手术的大小和持续时间分析术后并发症发生率。对于规模相似的手术,长期预防用药并不比单剂量预防用药更具优势。得出的结论是,在主要的头颈手术病例中,单剂量预防用药似乎就足够了。